The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023, the benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to show promising growth in the forecast period.

The benign prostatic hyperplasia (BPH) treatment devices and equipment market has witnessed robust growth in recent years. Starting at $1.58 billion in 2023, it is projected to reach $1.69 billion in 2024, showcasing a commendable Compound Annual Growth Rate (CAGR) of 7.0%.

Factors Driving Growth

• Aging Population: Increasing prevalence of BPH is correlated with an aging demographic.
• Awareness and Diagnosis: Growing awareness and improved diagnostic capabilities contribute to market expansion.
• Healthcare Access: Improved healthcare access ensures more patients seek and receive treatment.
• Personalized Treatment: Advancements in personalized treatment options drive demand for specialized devices.

Future Outlook: A Strong Trajectory
The positive momentum is set to continue, with the market poised to grow to $2.14 billion in 2028, boasting a CAGR of 6.1%.

Catalysts for Future Growth

• Minimally Invasive Techniques: The adoption of minimally invasive procedures contributes to market expansion.
• Emerging Markets Growth: Increasing healthcare infrastructure in emerging markets drives demand.
• Regulatory Support: Favorable regulatory environments enhance market prospects.
• Value-Based Healthcare: A shift towards value-based healthcare models contributes to sustained growth.

Emerging Trends

• Non-Surgical and Office-Based Procedures: Convenience and reduced recovery times drive the shift towards non-surgical options.
• Laser and Radiofrequency Technologies: Advancements in technologies offer more effective and targeted treatments.
• Telemedicine and Remote Consultation: The integration of telemedicine enhances accessibility and patient engagement.
• Patient Education and Engagement: Increasing focus on educating patients for informed decision-making.

Rising Prevalence: Fueling Demand
The escalating prevalence of Benign Prostatic Hyperplasia (BPH) is a primary driver for the growing demand for treatment devices and equipment.

Statistical Insights

• In 2021, over 14 million men in the United States exhibited symptoms of BPH.
• Globally, an estimated 30 million men experience symptoms related to BPH.

Market Players
Major companies contributing to the BPH treatment devices and equipment market include:

• Karl Storz
• Lumenis Ltd.
• Olympus Corporation
• Urologix LLC
• Boston Scientific Inc.
• Endo International PLC
• NeoTract Inc.
• and others.

View More On The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Innovations Shaping the Market
Prostatic Artery Embolization (PAE)
Prostatic Artery Embolization (PAE) emerges as a groundbreaking development in BPH treatment. This minimally invasive technique, utilizing advanced imaging, reduces urinary symptoms without the need for surgery.

Corporate Moves: Olympus and Medi-Tate
In a strategic move, Olympus, a Japanese optics and reprography product manufacturer, acquired Medi-Tate in March 2021. This acquisition aims to strengthen Olympus’s urology business and broaden its portfolio of minimally invasive treatment products. Medi-Tate, based in Israel, focuses on enhancing men’s healthcare through effective non-surgical solutions.

Market Segmentation
The benign prostatic hyperplasia (BPH) treatment devices and equipment market is segmented based on various factors.

By Product

1. Resectoscopes
2. Radiofrequency Ablation Device
3. Urology Lasers
4. Prostatic Stents
5. Implants

By Procedure Type

1. Transurethral Needle Ablation (TUNA)
2. Transurethral Resection Of Prostate (TURP)
3. Transurethral Incision Of Prostate (TUIP)
4. Transurethral Microwave Thermotherapy (TUMT)
5. Laser Surgery
6. Other Procedure Types

By End-User

• Hospitals
• Ambulatory Surgical Centres (ASC)
• Clinics
• Home

Regional Dominance: North America Leading
In 2023, North America emerged as the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market.

In conclusion, the BPH treatment devices and equipment market is on an upward trajectory, driven by factors such as an aging population, increased awareness, and innovative technologies. As the market continues to evolve, stakeholders can anticipate a landscape marked by advancements in treatment options, strategic acquisitions, and a focus on patient-centric approaches.

Request A Sample Of The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=2431&type=smp

About Company:  TBRC
As a premier market research firm, we specialize in delivering comprehensive insights into customer behavior, market trends, product landscapes, and competitor analysis. Our expertise lies in extracting actionable intelligence through methods such as secondary research, expert interviews, proprietary data, and our extensive in-house knowledge base. With a dedicated team of over 350 experts spanning 28 countries, we curate a repository of 1.5 million datasets across 27 diverse industries, including services, manufacturing, healthcare, financial services, and technology. Our tailored intelligence services empower strategic decision-making, guiding you in market selection, customer targeting, and outmaneuvering competitors.